• HEDGEYE’S MARKET BRIEF
    Our FREE Investing Newsletter
    Get Exclusive Summer Sale Discounts

    By joining our email marketing list you agree to receive marketing emails from Hedgeye. You may unsubscribe at any time by clicking the unsubscribe link in one of the emails. Not available for current subscribers to that product. Use of Hedgeye and any other products available through hedgeye.com are subject to our Terms Of Service and Privacy Policy New users only.

Takeaway: Join the policy team as we discuss the prospects for Part D donut hole redux, repeal of ACA taxes and the future of the Farm Bill '18

CALL INVITE - 11/19 @2PM LAME DUCK AGENDA | LAST CHANCE FOR PHARMA ON PART D?  - Mid term recap Cartoon

During the lame-duck session, Congress will have to agree to a stopgap measure to fund roughly a quarter of the government’s operations before the current continuing resolution expires on December 7 – with a government shutdown looming over funding for the border wall.  There are a number of other major issues/expiring programs Congress needs to address before the end of the year:

  • Part D donut hole fix - Will good policy (and PhaRMA) prevail with a reversal of Feb. 2018 decision to shift more liability to manufacturers?
  • CREATES Act - Compromise vehicle for Part D fix?
  • Farm Bill/ Food Assistance [SNAP] - Will McConnell get Cannabis language or a punt?
  • Tax Extenders + Technical Corrections to the Tax Cuts and Jobs Act of 2018
  • Employer relief from employer mandate
  • Changes to Health Savings Accounts
  • Repeal/delay of ACA-era taxes
  • Extension of Medicare as secondary payer for dialysis patients.

Please join us for our outlook on these issues and more on Monday, November 19 at 2:00 pm. Click here for link to video link and materials.

Participant Dialing Instructions

Toll Free:

Toll:

UK: 0

Confirmation Number: 13685116

Emily Evans
Managing Director – Health Policy



Twitter
LinkedIn

Thomas Tobin
Managing Director


Twitter
LinkedIn

Andrew Freedman, CFA
Director


Twitter
LinkedIn